Aprepitant Kit
NDC Package 68462-112-33
Package Information
Aprepitant kits is aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). This formulation utilizes a kit delivery system. Marketed by Glenmark Pharmaceuticals Inc., Usa, this product is identified by NDC 68462-112 and is authorized under FDA application ANDA207777.
Identification & Billing
- RxCUI: 403810 - aprepitant 80 MG Oral Capsule
- RxCUI: 403811 - aprepitant 125 MG Oral Capsule
- RxCUI: 644088 - aprepitant 40 MG Oral Capsule
- RxCUI: 754508 - {1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack
- RxCUI: 754508 - aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68462 - Glenmark Pharmaceuticals Inc., Usa
- 68462-112 - Aprepitant
- 68462-112-33 - 1 KIT in 1 DOSE PACK * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK
- 68462-112 - Aprepitant
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68462-112-33 identifies a specific commercial package of 1 kit in 1 dose pack * 2 capsule in 1 blister pack * 1 capsule in 1 blister pack of Aprepitant, a human prescription drug labeled by Glenmark Pharmaceuticals Inc., Usa. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Pharmaceuticals Inc., Usa on October 12, 2017. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Aprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting.
How is this Glenmark Pharmaceuticals Inc., Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68462011233. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
